Patient Data In Drug Reviews Would Be Encouraged In Proposed Amendment To User Fee Bill

 
• By Brenda Sandburg
Patient experience
FDA may have to disclose how it uses patient experience data in drug reviews • Source: Shutterstock

More from US FDA

More from Agency Leadership